95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.91%
Negative revenue growth while OR stands at 9.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.92%
Negative gross profit growth while OR is at 10.18%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.76%
Negative EBIT growth while OR is at 15.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-16.76%
Negative operating income growth while OR is at 7.56%. Joel Greenblatt would press for urgent turnaround measures.
-10.50%
Negative net income growth while OR stands at 26.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-16.67%
Negative EPS growth while OR is at 21.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-18.18%
Negative diluted EPS growth while OR is at 21.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
1.61%
Share count expansion well above OR's 0.41%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
1.64%
Diluted share count expanding well above OR's 0.35%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.76%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
156.85%
10Y revenue/share CAGR at 75-90% of OR's 191.83%. Bill Ackman would press for new markets or product lines to narrow the gap.
-43.56%
Negative 5Y CAGR while OR stands at 29.95%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
90.09%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
3232.53%
5Y OCF/share CAGR above 1.5x OR's 192.29%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
785.71%
3Y OCF/share CAGR under 50% of OR's 22738.42%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
No Data
No Data available this quarter, please select a different quarter.
2933.79%
5Y net income/share CAGR above 1.5x OR's 117.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
658.94%
3Y net income/share CAGR above 1.5x OR's 86.14%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
698.75%
Positive growth while OR is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
729.85%
Positive 5Y equity/share CAGR while OR is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
1036.77%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.03%
Firm’s AR is declining while OR shows 8.62%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
3.87%
Similar asset growth to OR's 3.85%. Walter Schloss finds parallel expansions or investment rates.
2.31%
Under 50% of OR's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.62%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.